NSE · SHARDACROP · Agro Chemicals
Sharda Cropchem Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹969 Cr with net profit ₹141 Cr — a 14.51% net margin, versus 12.59% the period before.
Shareholding
As of 2026-06-30
- Promoter74.82%
- Public12.88%
- FII3.11%
- DII9.18%
63,572 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.72× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pesticides / Agrochemicals - Indian · ranked #4 of 29 by market cap · medians across 26 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| UPL Limited | ₹50,850 Cr | 47.94 | 1.46 | 5.54% | 3.71% |
| PI Industries Ltd. | ₹42,137 Cr | 210.4 | 3.76 | 11.76% | 0.2% |
| Sumitomo Chemical India Ltd. | ₹25,377 Cr | 44.4 | 7.49 | 16.02% | 17.86% |
| Sharda Cropchem Ltd.(this company) | ₹7,398 Cr | 23.22 | 2.36 | 21.71% | 12.93% |
| Dhanuka Agritech Ltd. | ₹4,655 Cr | 47.61 | 2.77 | 21.17% | 14.59% |
| NACL Industries Limited | ₹4,417 Cr | — | 6.47 | 2.49% | 0.29% |
| Rallis India Ltd. | ₹3,760 Cr | 28.19 | 2.02 | 9.99% | 6.31% |
| Bhagiradha Chemicals & Industries Ltd. | ₹3,489 Cr | 868.06 | 5 | 2.6% | 3.39% |
| Bharat Rasayan Ltd. | ₹2,106 Cr | 55.21 | 1.65 | 11.43% | 11.73% |
| Insecticides India Ltd. | ₹1,810 Cr | 154.76 | 1.48 | 0.11% | 6.51% |
AI analysis
AI-generated · google/gemini-2.5-flashSharda Cropchem Ltd. is listed with a market capitalization of Rs 7930 Cr. The company reported revenue of Rs 4379.39 Cr and an EPS of 33.74. The 52-week high for the share price was Rs 1297, and the 52-week low was Rs 755.55.
Positives
- +The company has a low debt-to-equity ratio of 0.01.
- +Promoter holding is stable at 74.821% as of June 30, 2026.
- +There are no shares pledged by promoters (0%).
Negatives
- −DII shareholding decreased from 14.62% in Jun 2018 to 9.18% in Jun 2026, representing a 37.14% reduction over the period.
- −FII shareholding decreased from 6.03% in Jun 2018 to 3.11% in Jun 2026, representing a 48.42% reduction over the period.
- −The quarterly net profit in Sept 2025 was Rs 74.31 Cr, which is lower than the Rs 142.78 Cr reported in Jun 2025.
Financial Performance
For the fiscal year ending March 2026, Sharda Cropchem Ltd. recorded revenue of Rs 5409.8242 Cr and a net profit of Rs 680.861 Cr. The EBITDA for the same period was Rs 857.263 Cr. Quarterly performance for March 2026 saw revenue of Rs 2064.9 Cr and a net profit of Rs 318.64 Cr.
Profitability & Returns
The company's Return on Equity (ROE) stands at 12.9%, while the Return on Capital Employed (ROCE) is 15.78%. The Earnings Per Share (EPS) for the company is 33.74, and the price-to-earnings (P/E) ratio is 16.92. The book value per share is Rs 277.16.
Balance Sheet
Sharda Cropchem Ltd. maintains a low debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing. Specific details regarding overall debt levels or cash reserves are not available in the provided data.
Ownership & Pledges
As of June 30, 2026, promoter holding in Sharda Cropchem Ltd. is 74.821%. There are no shares pledged by the promoters, indicating financial stability regarding promoter shareholding.
Historical Shareholding
Promoter holding has remained consistently high, at 74.7783% from June 30, 2017, to June 30, 2018. DII holding decreased from 14.6192% in June 2018 to 9.1815% in June 2026. FII holding also showed a decline from 6.03% in June 2018 to 3.1144% in June 2026. Public shareholding for Q1 FY27 is 12.8831%.
Data as of — price: 2026-07-31 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.